Phosphorus06.08.20
Phosphorus, a genomics firm headquartered in New York City with a lab in Secaucus, New Jersey, has been granted Emergency Use Authorization by the FDA for its COVID-19 saliva test that features at-home sample collection. The test is available by ordering online, as well as through partnerships between employers and health care providers with the goal of safely resuming operations. This authorization by the federal government comes after a rigorous round of validation studies.
This is the second at-home unsupervised saliva test granted authorization so far by the FDA.
Using a saliva-based collection method is simple and less intrusive than the prevalent swab-based methods. This ease-of-use is a key characteristic to enabling the widespread and repetitive testing protocols proposed by experts to contain the COVID-19 pandemic.
To order the tests, consumers must follow these steps:
Phosphorus is also partnering with health care facilities and employers to conduct COVID-19 testing while limiting exposure risks by collecting samples at home.
“COVID testing is essential to getting life back to normal. This test will allow people from coast to coast to be tested from the safety of their homes with the oversight of medical personnel,” said Alexander Bisignano, co-founder and CEO of Phosphorus. “We thank the FDA for their hard work throughout this crisis and the quick action they have taken. We look forward to helping the country re-open.”
Phosphorus provides advanced genomic tests using next generation sequencing (NGS) technologies to healthcare providers and hospitals. The Phosphorus laboratory has re-oriented its operations to focus on COVID-19 testing in order to bring its testing methodologies and experience in genomics to this public health crisis.
This is the second at-home unsupervised saliva test granted authorization so far by the FDA.
Using a saliva-based collection method is simple and less intrusive than the prevalent swab-based methods. This ease-of-use is a key characteristic to enabling the widespread and repetitive testing protocols proposed by experts to contain the COVID-19 pandemic.
To order the tests, consumers must follow these steps:
- Choose and order the test through the online checkout process.
- Complete a medical questionnaire.
- An independent physician will review the medical information.
- Once approved, a sample collection kit will be shipped to the consumer’s home.
- Test results will be available within 72 hours after receipt at the laboratory and will be accompanied by a consultation from medical personnel.
Phosphorus is also partnering with health care facilities and employers to conduct COVID-19 testing while limiting exposure risks by collecting samples at home.
“COVID testing is essential to getting life back to normal. This test will allow people from coast to coast to be tested from the safety of their homes with the oversight of medical personnel,” said Alexander Bisignano, co-founder and CEO of Phosphorus. “We thank the FDA for their hard work throughout this crisis and the quick action they have taken. We look forward to helping the country re-open.”
Phosphorus provides advanced genomic tests using next generation sequencing (NGS) technologies to healthcare providers and hospitals. The Phosphorus laboratory has re-oriented its operations to focus on COVID-19 testing in order to bring its testing methodologies and experience in genomics to this public health crisis.